These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides. Petch AK; Sohail M; Hughes MD; Benter I; Darling J; Southern EM; Akhtar S Biochem Pharmacol; 2003 Sep; 66(5):819-30. PubMed ID: 12948863 [TBL] [Abstract][Full Text] [Related]
43. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma. Soini Y; Mannermaa A; Winqvist R; Kamel D; Poikonen K; Kiviniemi H; Pääkkö P J Histochem Cytochem; 1994 Jun; 42(6):795-803. PubMed ID: 7910618 [TBL] [Abstract][Full Text] [Related]
44. [An EGFR antisense oligodeoxynucleotides and its phosphorothioate analogue inhibit the growth of human hepatocarcinoma BEL-7404 cells]. Lin JQ; Xu ZS; Zhang HY; Yang ZW; Xu YH Shi Yan Sheng Wu Xue Bao; 1995 Sep; 28(3):241-6. PubMed ID: 8571707 [TBL] [Abstract][Full Text] [Related]
46. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo. Del Bufalo D; Cucco C; Leonetti C; Citro G; D'Agnano I; Benassi M; Geiser T; Zon G; Calabretta B; Zupi G Br J Cancer; 1996 Aug; 74(3):387-93. PubMed ID: 8695353 [TBL] [Abstract][Full Text] [Related]
47. Antisense phosphorothioate oligonucleotides targeted to the human chemokine receptor CXCR4. Kusunoki A; Miyano-Kurosaki N; Kimura T; Takai K; Yamamoto N; Gushima H; Takaku H Nucleosides Nucleotides Nucleic Acids; 2000; 19(10-12):1709-19. PubMed ID: 11200267 [TBL] [Abstract][Full Text] [Related]
48. The use of antisense oligodeoxynucleotides (aODNs) for the therapy of cancer. Alama A; Barbieri F; Bottini F; Nicolin A Drugs Exp Clin Res; 1991; 17(12):575-9. PubMed ID: 1841051 [TBL] [Abstract][Full Text] [Related]
49. [Antisense nucleic acid therapy of influenza virus]. Hatta T; Abe T; Takai K; Takaku H Nihon Rinsho; 1997 Oct; 55(10):2765-71. PubMed ID: 9360404 [TBL] [Abstract][Full Text] [Related]
51. Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines. Ciardiello F; Caputo R; Troiani T; Borriello G; Kandimalla ER; Agrawal S; Mendelsohn J; Bianco AR; Tortora G Int J Cancer; 2001 Jul; 93(2):172-8. PubMed ID: 11410862 [TBL] [Abstract][Full Text] [Related]
52. The mechanism of c-erbB-2 gene product increase in stomach cancer cell lines. Bae CD; Park SE; Seong YS; Kimm SW; Park JB; Park JB J Korean Med Sci; 1993 Apr; 8(2):153-9. PubMed ID: 8104420 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. Dean NM; McKay R; Condon TP; Bennett CF J Biol Chem; 1994 Jun; 269(23):16416-24. PubMed ID: 7911467 [TBL] [Abstract][Full Text] [Related]
54. Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by liposomally encapsulated antisense phosphorothioate oligonucleotides in MDCK cells. Abe T; Suzuki S; Hatta T; Takai K; Yokota T; Takaku H Antivir Chem Chemother; 1998 May; 9(3):253-62. PubMed ID: 9875404 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications. Calabretta B Cancer Res; 1991 Sep; 51(17):4505-10. PubMed ID: 1873794 [No Abstract] [Full Text] [Related]
56. Inhibition of CD4 expression by antisense oligonucleotides in PMA-treated lymphocytes. Rabanal M; Franch A; Noé V; Ciudad CJ; Castell M; Castellote C Antisense Nucleic Acid Drug Dev; 2002 Dec; 12(6):399-410. PubMed ID: 12568314 [TBL] [Abstract][Full Text] [Related]
57. Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides. Jachimczak P; Hessdörfer B; Fabel-Schulte K; Wismeth C; Brysch W; Schlingensiepen KH; Bauer A; Blesch A; Bogdahn U Int J Cancer; 1996 Jan; 65(3):332-7. PubMed ID: 8575854 [TBL] [Abstract][Full Text] [Related]
58. Enhancement of methylcholanthrene-induced neoplastic transformation in murine C3H 10T1/2 fibroblasts by antisense phosphorothioate oligodeoxynucleotide sequences. Lesoon-Wood LA; Pierce LM; Lau AF; Cooney RV Cancer Lett; 1999 Dec; 147(1-2):163-73. PubMed ID: 10660102 [TBL] [Abstract][Full Text] [Related]
59. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells. Giles RV; Spiller DG; Grzybowski J; Clark RE; Nicklin P; Tidd DM Nucleic Acids Res; 1998 Apr; 26(7):1567-75. PubMed ID: 9512525 [TBL] [Abstract][Full Text] [Related]
60. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells. Citro G; Szczylik C; Ginobbi P; Zupi G; Calabretta B Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]